See also this year's filing and all EDGAR filings for this company.
PDF Report 0001629205_2023_Innovation1_Biotech_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 2.4372474585114677e-08, 'aggregate_val': 41029893, 'exp_sum': 41029892, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 362359, 'ResearchAndDevelopmentExpense': 201165, 'remainder_Expenses': 40466368}} |
Graph
Absolute values for 0001629205, Innovation1 Biotech Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 286,956 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,615 |
| 3 | remainder_Assets | 43,673,842 |
| 4 | LiabilitiesCurrent | 29,812,416 |
| 5 | LiabilitiesNoncurrent | 11,298,423 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 362,359 |
| 9 | ResearchAndDevelopmentExpense | 201,165 |
| 10 | remainder_Expenses | 40,466,369 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -152,080 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,963,413 |
| 1 | Liabilities | 41,110,839 |
| 2 | Expenses | 41,029,893 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 2,852,574 |
| 5 | NetIncome | -41,181,973 |
| 6 | ComprehensiveNetIncome | -41,181,973 |
| 7 | BaseVar | 63,128,112 |
| 8 | EconomicCapitalRatio | -0.853 |
Edgar->Model Mapping
Feature Distribution
Change over Time
